Literature DB >> 21341969

Medically unexplained dyspnea: partly moderated by dysfunctional (thoracic dominant) breathing pattern.

Rosalba Courtney1, Jan van Dixhoorn, Kenneth Mark Greenwood, Els L M Anthonissen.   

Abstract

BACKGROUND: Dysfunctional breathing (DB) may contribute to disproportionate dyspnea and other medically unexplained symptoms. The extent of dysfunctional breathing is often evaluated using the Nijmegen Questionnaire (NQ) or by the presence of abnormal breathing patterns. The NQ was originally devised to evaluate one form of dysfunctional breathing - hyperventilation syndrome. However, the symptoms identified by the NQ are not primarily due to hypocapnia and may be due to other causes including breathing pattern dysfunction.
OBJECTIVES: The relationships between breathing pattern abnormalities and the various categories of NQ symptoms including respiratory or dyspnea symptoms have not been investigated. This study investigates these relationships.
METHOD: 62 patients with medically unexplained complaints, that seemed to be associated with tension and breathing dysfunction, were referred, or self-referred, for breathing and relaxation therapy. Dysfunctional breathing symptoms and breathing patterns were assessed at the beginning and end of treatments using the NQ for assessment of DB symptoms, and the Manual Assessment of Respiratory Motion (MARM) to quantify the extent of thoracic dominant breathing. Subscales for the NQ were created in 4 categories, tension, central neurovascular, peripheral neurovascular and dyspnea. Relationships between the NQ (sum scores and subscales) and the MARM were explored.
RESULTS: Mean NQ scores were elevated and mean MARM values for thoracic breathing were also elevated. There was a small correlation pre-treatment between MARM and NQ (r=0.26, p<0.05), but classification of subjects as normal/abnormal on both measurements agreed in 74% (p < 0.001) of patients. From the sub scores of NQ only the respiratory or 'dyspnea' items correlated with the MARM values. Dyspnea was only elevated for subjects with abnormal MARM. After treatment, both MARM and NQ returned to normal values (p< 0.0001). Changes in NQ were largest for subjects with abnormal MARM pre-treatment. There was a large interaction between the change in the NQ sub score dyspnea and initial MARM values. (p<0.001).

Entities:  

Mesh:

Year:  2011        PMID: 21341969     DOI: 10.3109/02770903.2011.554942

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  7 in total

1.  DEVELOPMENT OF A SCREENING PROTOCOL TO IDENTIFY INDIVIDUALS WITH DYSFUNCTIONAL BREATHING.

Authors:  Kyle Kiesel; Tonya Rhodes; Jacob Mueller; Alyssa Waninger; Robert Butler
Journal:  Int J Sports Phys Ther       Date:  2017-10

Review 2.  Respiratory therapy for the treatment of anxiety: Meta-analytic review and regression.

Authors:  Teresa M Leyro; Mark V Versella; Min-Jeong Yang; Hannah R Brinkman; Danielle L Hoyt; Paul Lehrer
Journal:  Clin Psychol Rev       Date:  2021-01-24

3.  The Nijmegen Questionnaire and dysfunctional breathing.

Authors:  Jan van Dixhoorn; Hans Folgering
Journal:  ERJ Open Res       Date:  2015-05-15

Review 4.  Breathing training for dysfunctional breathing in asthma: taking a multidimensional approach.

Authors:  Rosalba Courtney
Journal:  ERJ Open Res       Date:  2017-12-08

Review 5.  Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page series.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2021-08-17       Impact factor: 2.300

6.  Negative mood and alcohol problems are related to respiratory dynamics in young adults.

Authors:  Paul Lehrer; Jennifer F Buckman; Eun-Young Mun; Evgeny G Vaschillo; Bronya Vaschillo; Tomoko Udo; Suchismita Ray; Tam Nguyen; Marsha E Bates
Journal:  Appl Psychophysiol Biofeedback       Date:  2013-12

7.  The impact of a dedicated physiotherapist clinic for children with dysfunctional breathing.

Authors:  Nicola J Barker; Heather Elphick; Mark L Everard
Journal:  ERJ Open Res       Date:  2016-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.